162 related articles for article (PubMed ID: 24673683)
1. Defective antiviral CD8 T-cell response and viral clearance in the absence of c-Jun N-terminal kinases.
Wang YQ; Ma X; Lu L; Zhao L; Zhang X; Xu Q; Wang Y
Immunology; 2014 Aug; 142(4):603-13. PubMed ID: 24673683
[TBL] [Abstract][Full Text] [Related]
2. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity.
Arbour N; Naniche D; Homann D; Davis RJ; Flavell RA; Oldstone MB
J Exp Med; 2002 Apr; 195(7):801-10. PubMed ID: 11927625
[TBL] [Abstract][Full Text] [Related]
3. Obligatory requirement for antibody in recovery from a primary poxvirus infection.
Chaudhri G; Panchanathan V; Bluethmann H; Karupiah G
J Virol; 2006 Jul; 80(13):6339-44. PubMed ID: 16775322
[TBL] [Abstract][Full Text] [Related]
4. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation.
Conze D; Krahl T; Kennedy N; Weiss L; Lumsden J; Hess P; Flavell RA; Le Gros G; Davis RJ; Rincón M
J Exp Med; 2002 Apr; 195(7):811-23. PubMed ID: 11927626
[TBL] [Abstract][Full Text] [Related]
5. The POSH/JIP-1 scaffold network regulates TCR-mediated JNK1 signals and effector function in CD8(+) T cells.
Cunningham CA; Knudson KM; Peng BJ; Teixeiro E; Daniels MA
Eur J Immunol; 2013 Dec; 43(12):3361-71. PubMed ID: 23963642
[TBL] [Abstract][Full Text] [Related]
6. Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection.
Karupiah G; Buller RM; Van Rooijen N; Duarte CJ; Chen J
J Virol; 1996 Dec; 70(12):8301-9. PubMed ID: 8970949
[TBL] [Abstract][Full Text] [Related]
7. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
[TBL] [Abstract][Full Text] [Related]
8. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
Liu J; Minemoto Y; Lin A
Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.
Panchanathan V; Chaudhri G; Karupiah G
J Virol; 2006 Jul; 80(13):6333-8. PubMed ID: 16775321
[TBL] [Abstract][Full Text] [Related]
10. Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.
Chaudhri G; Panchanathan V; Buller RM; van den Eertwegh AJ; Claassen E; Zhou J; de Chazal R; Laman JD; Karupiah G
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9057-62. PubMed ID: 15184649
[TBL] [Abstract][Full Text] [Related]
11. Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host.
Fang M; Sigal LJ
J Immunol; 2006 Dec; 177(11):8027-36. PubMed ID: 17114476
[TBL] [Abstract][Full Text] [Related]
12. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.
Kook S; Zhan X; Kaoud TS; Dalby KN; Gurevich VV; Gurevich EV
J Biol Chem; 2013 Dec; 288(52):37332-42. PubMed ID: 24257757
[TBL] [Abstract][Full Text] [Related]
13. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
[TBL] [Abstract][Full Text] [Related]
14. JNK2 regulates the functional plasticity of naturally occurring T regulatory cells and the enhancement of lung allergic responses.
Joetham A; Schedel M; Takeda K; Jia Y; Ashino S; Dakhama A; Lluis A; Okamoto M; Gelfand EW
J Immunol; 2014 Sep; 193(5):2238-47. PubMed ID: 25070841
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
Gancz D; Donin N; Fishelson Z
Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
[TBL] [Abstract][Full Text] [Related]
16. c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation.
Sabapathy K; Kallunki T; David JP; Graef I; Karin M; Wagner EF
J Exp Med; 2001 Feb; 193(3):317-28. PubMed ID: 11157052
[TBL] [Abstract][Full Text] [Related]
17. Induction of natural killer cell responses by ectromelia virus controls infection.
Parker AK; Parker S; Yokoyama WM; Corbett JA; Buller RM
J Virol; 2007 Apr; 81(8):4070-9. PubMed ID: 17287257
[TBL] [Abstract][Full Text] [Related]
18. Protective role of c-Jun N-terminal kinase-2 (JNK2) in ibuprofen-induced acute liver injury.
Zoubek ME; Woitok MM; Sydor S; Nelson LJ; Bechmann LP; Lucena MI; Andrade RJ; Bast A; Koek GH; Trautwein C; Cubero FJ
J Pathol; 2019 Jan; 247(1):110-122. PubMed ID: 30264435
[TBL] [Abstract][Full Text] [Related]
19. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
[TBL] [Abstract][Full Text] [Related]
20. Hepatotoxicity mediated by pyrazole (cytochrome P450 2E1) plus tumor necrosis factor alpha treatment occurs in c-Jun N-terminal kinase 2-/- but not in c-Jun N-terminal kinase 1-/- mice.
Wang X; Wu D; Yang L; Cederbaum AI
Hepatology; 2011 Nov; 54(5):1753-66. PubMed ID: 21748763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
